share_log
Moomoo 24/7 ·  02/28 07:12

Can-Fite BioPharma Announced Notice Of Allowance In Canada For Its Patent Application Regarding Se Of Namodenoson For The Reduction Of Liver Fat In Patients With NASH

Can-Fite BioPharma宣佈加拿大批准其有關用於減少NASH患者肝脂肪的Se的專利申請

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論